Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

Take-at-home COVID drug molnupiravir may be on its way — but vaccination is still our first line of defence

By Nial Wheate, Associate Professor of the Sydney Pharmacy School, University of Sydney
Share this article
The Australian government has pre-purchased 300,000 courses of an experimental antiviral oral drug called molnupiravir.

Interim results announced by the company, US pharmaceutical Merck, show the drug halved the number of patients who ended up in hospital due to COVID. No patient who took the drug died from the virus.

But the drug isn’t yet available for dispensing from pharmacies because it hasn’t received approval from Australia’s drug regulator, the Therapeutic…


Read complete article

© The Conversation -


Follow us on ...
Facebook Twitter